Paul Mann co-founded ASP Isotopes in September 2021 and serves as the Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer. Paul has more than 20 years of experience on Wall Street investing in healthcare and chemicals companies. He’s worked at Soros Fund Management, Highbridge Capital Management and Morgan Stanley. Paul started his career as a research scientist at Procter and Gamble, and he is named as the inventor of numerous skin creams in the Oil of Olay range of cosmetics. Paul has an MA (Cantab) and a Master of Engineering from Cambridge University, UK where he studied Natural Sciences and Chemical Engineering, and he is a CFA charter holder.
Sergey Vasnetsov has served on the Board of Directors since October 2021. He is the founder of ChemBridges strategy consulting firm. From 2010 – 2016, he was Senior VP of Strategic Planning and Transactions at LyondellBasell (NYSE: LYB). Prior to that, Sergey was a Managing Director of Equity Research at Barclays Capital and Lehman Brothers. He started his career at Union Carbide in 1990. Sergey has a Master of Science in Catalysis from the Novosibirsk University, Russia. He was a George Soros Scholar at Oxford University (UK) and later earned an MBA in Finance from Rutgers University (US).
Dr. Strydom has over thirty years’ of experience in isotope enrichment. He co-developed the isotope separation technology, known as “Aerodynamic Separation Process” (ASP), which is the technology backbone of ASP Isotopes. Hendrik’s work on the separation of isotopes started when he was employed as a scientist at the South African Atomic Energy Corporation (AEC), where he specialized in the laser separation of heavy isotopes. Hendrik left AEC in 1993 to co-found Klydon, an isotope enrichment company based in South Africa. Dr. Strydom holds a BSc(Ed) (Physics & Maths) (1981), followed by the Hons course at the University of Pretoria (1983). Dr Strydom also holds an MSc (Physics) from the University of Port Elizabeth (1990) and a PhD (Physics) (2000) from the University of Natal (Durban).
Robert Ainscow co-founded ASP Isotopes in September 2021 and serves as the Chief Financial Officer. He has more than 20 years experience in finance, having worked at Morgan Stanley, Bear Stearns and Investec Bank. He started his career in the legal and regulatory department with responsibility for M&A and capital markets oversight. He later transitioned into the capital markets business units and became a Senior Transactor, structuring a broad range of bespoke transactions and funding programs for balance sheet assets and on behalf of clients, more latterly for smaller, early-stage companies in niche markets as an advisor, director, or founder. Mr Ainscow holds a BA (Law & Modern Languages) from Bristol UWE in the UK.
Japie Grant is a process engineer with 40 years of experience in isotope separation, simulation and project management. Japie started his career at the Uranium Enrichment Corporation of South Africa (UCOR) and specialized in the development of alternative cascading techniques for asymmetrical separation elements. Japie was the systems engineer responsible for the design and commissioning of four isotope separation plants using ASP’s technology. He holds an MSc in engineering from the University of Pretoria.
Robert Ainscow co-founded ASP Isotopes in September 2021 and serves as the Chief Financial Officer. He has more than 20 years experience in finance, having worked at Morgan Stanley, Bear Stearns and Investec Bank. He started his career in the legal and regulatory department with responsibility for M&A and capital markets oversight. He later transitioned into the capital markets business units and became a Senior Transactor, structuring a broad range of bespoke transactions and funding programs for balance sheet assets and on behalf of clients, more latterly for smaller, early-stage companies in niche markets as an advisor, director, or founder. Mr Ainscow holds a BA (Law & Modern Languages) from Bristol UWE in the UK.
Materials
Chemicals
Other Basic Inorganic Chemical Manufacturing (325180)
Miscellaneous Chemical Products (2890)
